"World's Most Complete Market Research Reports Repository"

Global Psoriasis Therapeutics Market Size, Status and Forecast 2018-2025

This report focuses on the global Psoriasis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriasis Therapeutics development in United States, Europe and China.

Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.
In 2017, the global Psoriasis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G & W Laboratories Inc.

Market segment by Type, the product can be split into
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others

Market segment by Application, split into
Oral
Parenteral
Topical

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Psoriasis Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Psoriasis Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Psoriasis Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type (2013-2025)
1.4.2 TNF Inhibitors
1.4.3 PDE4 Inhibitors
1.4.4 Interleukin Blockers
1.4.5 Others
1.5 Market by Application
1.5.1 Global Psoriasis Therapeutics Market Share by Application (2013-2025)
1.5.2 Oral
1.5.3 Parenteral
1.5.4 Topical
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Psoriasis Therapeutics Market Size
2.2 Psoriasis Therapeutics Growth Trends by Regions
2.2.1 Psoriasis Therapeutics Market Size by Regions (2013-2025)
2.2.2 Psoriasis Therapeutics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Psoriasis Therapeutics Market Size by Manufacturers
3.1.1 Global Psoriasis Therapeutics Revenue by Manufacturers (2013-2018)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Psoriasis Therapeutics Key Players Head office and Area Served
3.3 Key Players Psoriasis Therapeutics Product/Solution/Service
3.4 Date of Enter into Psoriasis Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Psoriasis Therapeutics Market Size by Type (2013-2018)
4.2 Global Psoriasis Therapeutics Market Size by Application (2013-2018)

5 United States
5.1 United States Psoriasis Therapeutics Market Size (2013-2018)
5.2 Psoriasis Therapeutics Key Players in United States
5.3 United States Psoriasis Therapeutics Market Size by Type
5.4 United States Psoriasis Therapeutics Market Size by Application

6 Europe
6.1 Europe Psoriasis Therapeutics Market Size (2013-2018)
6.2 Psoriasis Therapeutics Key Players in Europe
6.3 Europe Psoriasis Therapeutics Market Size by Type
6.4 Europe Psoriasis Therapeutics Market Size by Application

7 China
7.1 China Psoriasis Therapeutics Market Size (2013-2018)
7.2 Psoriasis Therapeutics Key Players in China
7.3 China Psoriasis Therapeutics Market Size by Type
7.4 China Psoriasis Therapeutics Market Size by Application

8 Japan
8.1 Japan Psoriasis Therapeutics Market Size (2013-2018)
8.2 Psoriasis Therapeutics Key Players in Japan
8.3 Japan Psoriasis Therapeutics Market Size by Type
8.4 Japan Psoriasis Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Psoriasis Therapeutics Market Size (2013-2018)
9.2 Psoriasis Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Psoriasis Therapeutics Market Size by Type
9.4 Southeast Asia Psoriasis Therapeutics Market Size by Application

10 India
10.1 India Psoriasis Therapeutics Market Size (2013-2018)
10.2 Psoriasis Therapeutics Key Players in India
10.3 India Psoriasis Therapeutics Market Size by Type
10.4 India Psoriasis Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Psoriasis Therapeutics Market Size (2013-2018)
11.2 Psoriasis Therapeutics Key Players in Central & South America
11.3 Central & South America Psoriasis Therapeutics Market Size by Type
11.4 Central & South America Psoriasis Therapeutics Market Size by Application

12 International Players Profiles
12.1 Astellas Pharma Inc.
12.1.1 Astellas Pharma Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Psoriasis Therapeutics Introduction
12.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2013-2018)
12.1.5 Astellas Pharma Inc. Recent Development
12.2 AstraZeneca plc
12.2.1 AstraZeneca plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Psoriasis Therapeutics Introduction
12.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2013-2018)
12.2.5 AstraZeneca plc Recent Development
12.3 Boehringer Ingelheim GmbH
12.3.1 Boehringer Ingelheim GmbH Company Details
12.3.2 Company Description and Business Overview
12.3.3 Psoriasis Therapeutics Introduction
12.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2013-2018)
12.3.5 Boehringer Ingelheim GmbH Recent Development
12.4 F. Hofffmann-La Roche
12.4.1 F. Hofffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Psoriasis Therapeutics Introduction
12.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2013-2018)
12.4.5 F. Hofffmann-La Roche Recent Development
12.5 GlaxoSmithKline plc
12.5.1 GlaxoSmithKline plc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Psoriasis Therapeutics Introduction
12.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2013-2018)
12.5.5 GlaxoSmithKline plc Recent Development
12.6 Merck & Co., Inc.
12.6.1 Merck & Co., Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Psoriasis Therapeutics Introduction
12.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2013-2018)
12.6.5 Merck & Co., Inc. Recent Development
12.7 Valeant Pharmaceuticals International, Inc.
12.7.1 Valeant Pharmaceuticals International, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Psoriasis Therapeutics Introduction
12.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2013-2018)
12.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
12.8 Biocon Limited
12.8.1 Biocon Limited Company Details
12.8.2 Company Description and Business Overview
12.8.3 Psoriasis Therapeutics Introduction
12.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2013-2018)
12.8.5 Biocon Limited Recent Development
12.9 Eli Lilly and Company
12.9.1 Eli Lilly and Company Company Details
12.9.2 Company Description and Business Overview
12.9.3 Psoriasis Therapeutics Introduction
12.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2013-2018)
12.9.5 Eli Lilly and Company Recent Development
12.10 G & W Laboratories Inc.
12.10.1 G & W Laboratories Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Psoriasis Therapeutics Introduction
12.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2013-2018)
12.10.5 G & W Laboratories Inc. Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Psoriasis Therapeutics Key Market Segments
Table Key Players Psoriasis Therapeutics Covered
Table Global Psoriasis Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Psoriasis Therapeutics Market Size Market Share by Type 2013-2025
Figure TNF Inhibitors Figures
Table Key Players of TNF Inhibitors
Figure PDE4 Inhibitors Figures
Table Key Players of PDE4 Inhibitors
Figure Interleukin Blockers Figures
Table Key Players of Interleukin Blockers
Figure Others Figures
Table Key Players of Others
Table Global Psoriasis Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
Figure Oral Case Studies
Figure Parenteral Case Studies
Figure Topical Case Studies
Figure Psoriasis Therapeutics Report Years Considered
Table Global Psoriasis Therapeutics Market Size 2013-2025 (Million US$)
Figure Global Psoriasis Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Psoriasis Therapeutics Market Size by Regions 2013-2025 (Million US$)
Table Global Psoriasis Therapeutics Market Size by Regions 2013-2018 (Million US$)
Table Global Psoriasis Therapeutics Market Share by Regions 2013-2018
Figure Global Psoriasis Therapeutics Market Share by Regions 2013-2018
Figure Global Psoriasis Therapeutics Market Share by Regions 2018
Table Market Top Trends
Table Global Psoriasis Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Psoriasis Therapeutics Market Share by Manufacturers (2013-2018)
Figure Global Psoriasis Therapeutics Market Share by Manufacturers in 2018
Table Global Psoriasis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Psoriasis Therapeutics Product/Solution/Service
Table Date of Enter into Psoriasis Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Psoriasis Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Global Psoriasis Therapeutics Market Size Share by Type (2013-2018)
Figure Global Psoriasis Therapeutics Market Size Market Share by Type (2013-2018)
Table Global Psoriasis Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Global Psoriasis Therapeutics Market Size Share by Application (2013-2018)
Figure Global Psoriasis Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Psoriasis Therapeutics Revenue Market Share by Application in 2017
Figure United States Psoriasis Therapeutics Market Size 2013-2018 (Million US$)
Table United States Key Players Psoriasis Therapeutics Revenue (2017-2018) (Million US$)
Table United States Key Players Psoriasis Therapeutics Market Share (2017-2018)
Table United States Psoriasis Therapeutics Market Size by Type (2013-2018) (Million US$)
Table United States Psoriasis Therapeutics Market Share by Type (2013-2018)
Table United States Psoriasis Therapeutics Market Size by Application (2013-2018) (Million US$)
Table United States Psoriasis Therapeutics Market Share by Application (2013-2018)
Figure Europe Psoriasis Therapeutics Market Size 2013-2018 (Million US$)
Table Europe Key Players Psoriasis Therapeutics Revenue (2017-2018) (Million US$)
Table Europe Key Players Psoriasis Therapeutics Market Share (2017-2018)
Table Europe Psoriasis Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Europe Psoriasis Therapeutics Market Share by Type (2013-2018)
Table Europe Psoriasis Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Europe Psoriasis Therapeutics Market Share by Application (2013-2018)
Figure China Psoriasis Therapeutics Market Size 2013-2018 (Million US$)
Table China Key Players Psoriasis Therapeutics Revenue (2017-2018) (Million US$)
Table China Key Players Psoriasis Therapeutics Market Share (2017-2018)
Table China Psoriasis Therapeutics Market Size by Type (2013-2018) (Million US$)
Table China Psoriasis Therapeutics Market Share by Type (2013-2018)
Table China Psoriasis Therapeutics Market Size by Application (2013-2018) (Million US$)
Table China Psoriasis Therapeutics Market Share by Application (2013-2018)
Figure Japan Psoriasis Therapeutics Market Size 2013-2018 (Million US$)
Table Japan Key Players Psoriasis Therapeutics Revenue (2017-2018) (Million US$)
Table Japan Key Players Psoriasis Therapeutics Market Share (2017-2018)
Table Japan Psoriasis Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Japan Psoriasis Therapeutics Market Share by Type (2013-2018)
Table Japan Psoriasis Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Japan Psoriasis Therapeutics Market Share by Application (2013-2018)
Figure Southeast Asia Psoriasis Therapeutics Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Psoriasis Therapeutics Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Psoriasis Therapeutics Market Share (2017-2018)
Table Southeast Asia Psoriasis Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Psoriasis Therapeutics Market Share by Type (2013-2018)
Table Southeast Asia Psoriasis Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Psoriasis Therapeutics Market Share by Application (2013-2018)
Figure India Psoriasis Therapeutics Market Size 2013-2018 (Million US$)
Table India Key Players Psoriasis Therapeutics Revenue (2017-2018) (Million US$)
Table India Key Players Psoriasis Therapeutics Market Share (2017-2018)
Table India Psoriasis Therapeutics Market Size by Type (2013-2018) (Million US$)
Table India Psoriasis Therapeutics Market Share by Type (2013-2018)
Table India Psoriasis Therapeutics Market Size by Application (2013-2018) (Million US$)
Table India Psoriasis Therapeutics Market Share by Application (2013-2018)
Figure Central & South America Psoriasis Therapeutics Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Psoriasis Therapeutics Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Psoriasis Therapeutics Market Share (2017-2018)
Table Central & South America Psoriasis Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Central & South America Psoriasis Therapeutics Market Share by Type (2013-2018)
Table Central & South America Psoriasis Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Central & South America Psoriasis Therapeutics Market Share by Application (2013-2018)
Table Astellas Pharma Inc. Company Details
Table Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2013-2018) (Million US$)
Figure Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table Astellas Pharma Inc. Recent Development
Table AstraZeneca plc Company Details
Table AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2013-2018)(Million US$)
Figure AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table AstraZeneca plc Recent Development
Table Boehringer Ingelheim GmbH Company Details
Table Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2013-2018)(Million US$)
Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table Boehringer Ingelheim GmbH Recent Development
Table F. Hofffmann-La Roche Company Details
Table F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2013-2018)(Million US$)
Figure F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table F. Hofffmann-La Roche Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2013-2018)(Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table GlaxoSmithKline plc Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2013-2018)(Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table Merck & Co., Inc. Recent Development
Table Valeant Pharmaceuticals International, Inc. Company Details
Table Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2013-2018)(Million US$)
Figure Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table Valeant Pharmaceuticals International, Inc. Recent Development
Table Biocon Limited Company Details
Table Biocon Limited Revenue in Psoriasis Therapeutics Business (2013-2018)(Million US$)
Figure Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table Biocon Limited Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2013-2018)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table Eli Lilly and Company Recent Development
Table G & W Laboratories Inc. Company Details
Table G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2013-2018)(Million US$)
Figure G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2013-2018)
Table G & W Laboratories Inc. Recent Development
Table Global Psoriasis Therapeutics Market Size by Regions (Million US$) 2018-2025
Figure Global Psoriasis Therapeutics Market Size Share by Regions (2018-2025)
Figure Global Psoriasis Therapeutics Market Size Share by Regions in 2025
Figure United States Psoriasis Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Europe Psoriasis Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure China Psoriasis Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Japan Psoriasis Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Psoriasis Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure India Psoriasis Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Psoriasis Therapeutics Market Size Forecast (2018-2025)(Million USD)
Table Global Psoriasis Therapeutics Market Size by Product (2018-2025) (Million US$)
Figure Global Psoriasis Therapeutics Market Size by Product (2018-2025)
Figure Global Psoriasis Therapeutics Market Size by Product in 2025
Table Global Psoriasis Therapeutics Market Size by Application (2018-2025) (Million US$)
Figure Global Psoriasis Therapeutics Market Size by Application (2018-2025)
Figure Global Psoriasis Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type